Literature DB >> 1667606

Autoradiographic distribution of alpha 2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscine.

H De Vos1, A Convents, J De Keyser, J P De Backer, I J Van Megen, G Ebinger, G Vauquelin.   

Abstract

The regional distribution of [3H]idazoxan and [3H]rauwolscine was studied autoradiographically in human brain. [3H]Idazoxan binds with high affinity to alpha 2 adrenoceptors as well as to non-adrenergic sites (NAIBS). [3H]Rauwolscine, besides binding to alpha 2 adrenoceptors, also binds to 5-HT1A receptors. Both radioligands labelled the same population of alpha 2 adrenoceptors, defined as the epinephrine-displaceable binding component. The highest densities of alpha 2 adrenoceptors occur in the leptomeninges, cerebral cortex and claustrum; lower densities were visualised in the basal ganglia, thalamus, pons, substantia nigra, cerebellum and medulla oblongata; no alpha 2 adrenoceptors were detected in amygdala and nucleus ruber. NAIBS were present in all the examined brain areas, with the highest densities found in the basal ganglia and substantia nigra. The finding that certain brain regions, such as the amygdala, contained NAIBS but no detectable alpha 2 adrenoceptors, suggests that the binding sites are independent from each other. The regional distribution of 5-HT1A receptors labelled by [3H]rauwolscine is in agreement with previous studies using [3H]8-OH-DPAT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667606     DOI: 10.1016/0006-8993(91)91675-q

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

Authors:  U B Schambra; G B Mackensen; M Stafford-Smith; D E Haines; D A Schwinn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha 2- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals.

Authors:  M Heider; R Schliebs; S Rossner; V Bigl
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

4.  The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

Authors:  Svetlana Semenova; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2010-06-03       Impact factor: 4.600

5.  [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.

Authors:  A Renouard; P S Widdowson; A Cordi
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

6.  Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.

Authors:  N J Mallard; A L Hudson; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  Evidence for altered alpha 2-adrenoceptor function following isolation-rearing in the rat.

Authors:  A J Fulford; S Butler; D J Heal; D A Kendall; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

Review 8.  Imaging of Reactive Astrogliosis by Positron Emission Tomography.

Authors:  Ryuichi Harada; Shozo Furumoto; Yukitsuka Kudo; Kazuhiko Yanai; Victor L Villemagne; Nobuyuki Okamura
Journal:  Front Neurosci       Date:  2022-02-08       Impact factor: 4.677

9.  Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain.

Authors:  Amit Kumar; Niina A Koistinen; Mona-Lisa Malarte; Inger Nennesmo; Martin Ingelsson; Bernardino Ghetti; Laetitia Lemoine; Agneta Nordberg
Journal:  Mol Psychiatry       Date:  2021-04-23       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.